A detailed history of Nuveen Asset Management, LLC transactions in Celcuity Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 58,934 shares of CELC stock, worth $848,649. This represents 0.0% of its overall portfolio holdings.

Number of Shares
58,934
Previous 32,441 81.67%
Holding current value
$848,649
Previous $700,000 37.86%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$14.1 - $20.78 $373,551 - $550,524
26,493 Added 81.67%
58,934 $965,000
Q4 2023

Feb 14, 2024

BUY
$8.7 - $15.02 $74,846 - $129,217
8,603 Added 36.09%
32,441 $472,000
Q2 2023

Aug 14, 2023

BUY
$9.39 - $12.18 $223,838 - $290,346
23,838 New
23,838 $261,000
Q2 2022

Aug 15, 2022

SELL
$5.35 - $10.11 $101,029 - $190,917
-18,884 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$17.35 - $24.87 $104,568 - $149,891
6,027 Added 46.88%
18,884 $389,000
Q2 2021

Aug 16, 2021

BUY
$14.25 - $30.93 $183,212 - $397,667
12,857 New
12,857 $309,000

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $215M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.